Abstract
Pancreatic ductal adenocarcinoma (PDAC), a common digestive system cancer, is highly malignant and has a poor disease outcome. Currently, all available examination and detection methods cannot accurately predict the clinical outcome. Therefore, it is extremely important to identify novel molecular biomarkers for personalized medication and to significantly improve the overall outcome. The "noncoding RNAs" (ncRNAs) are a group of RNAs that do not code for proteins, and they are categorized as structural RNAs and regulatory RNAs. It has been shown that microRNAs and long ncRNAs function as regulatory RNAs to affect the progression of various diseases. Many studies have confirmed a role for ncRNAs in the progression of PDAC during the last few years. Because of the significant role of ncRNAs in PDAC, ncRNA profiling may be used to predict PDAC outcome with high accuracy. This review comprehensively analyzes the value of ncRNAs as potential biomarkers to predict the outcome in PDAC and the possible mechanisms thereof.
Citations
Dec 29, 2015·Cancer Letters·Shangyou ZhengRufu Chen
Sep 24, 2015·Carcinogenesis·Chen-Yu Lin, Han-Mei Xu
Jul 2, 2015·BMC Medical Genomics·Juan Pablo LopezCarl Ernst
May 22, 2016·Expert Review of Molecular Diagnostics·Ulrike Erb, Margot Zöller
May 24, 2017·Oncogene·C LinH Xu
Nov 14, 2015·PloS One·Tyler A HerekChristine E Cutucache
Oct 2, 2017·Pathology Oncology Research : POR·Cheng SunWei Hu
Oct 9, 2019·Journal of Cellular Physiology·Sadegh FattahiHaleh Akhavan-Niaki
Mar 17, 2016·Oncotarget·Shouping XuDa Pang
Jan 3, 2018·Cancer Biology & Therapy·Yiran LiangQifeng Yang
Jul 29, 2016·World Journal of Gastroenterology : WJG·Sarah HeilerMargot Zöller
Sep 21, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yifan LianKeming Wang
Nov 30, 2019·Frontiers in Oncology·Chenhao ZhouQiongzhu Dong
Jun 8, 2017·Oncology Letters·Maria Celeste PalmarocchiPiercarlo Saletti
Nov 13, 2018·Journal of Cancer Research and Clinical Oncology·Tingting GuoPeng Gao
May 15, 2021·Frontiers in Oncology·Dakui LuoLi Yang